Read time:  10 minutes Written by:  Michael K. Lowe, MD Originally published on:  February 14, 2025 Three Key Points: 1.      New reason for hope .  Newer medications used for the treatment of diabetes, called GLP-1 agonists, are being investigated as potentially beneficial in dementia patients.   2.      Still work to do .  Although trends for GLP-1 benefit for dementia have been clearly demonstrated, there is not yet a direct cause-and-effect relationship established.   3.